El Salvador inks deal with Pfizer for 4.4 mln COVID-19 vaccine doses
Reuters2021-05-05
SAN SALVADOR, May 4 (Reuters) - El Salvador's president Nayib Bukele said on Twitter on Tuesday night that the Central American nation has signed an agreement with Pfizer Inc for 4.4 million COVID-19 vaccine doses.
"With this purchase, we guarantee uninterrupted immunization for our entire target population," said Bukele.
(Reporting by Nelson Renteria; Writing by Anthony Esposito; Editing by Tom Hogue)
((anthony.esposito@tr.com; +5255 5282 7140;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.